Company patents
iRhythm Technologies, Inc.
iRhythm Technologies, Inc. demonstrates a highly concentrated patent strategy, with 96.4% of its portfolio in Medical Diagnostics & Surgery, which saw a significant 90.0% growth in 2025 before a -36.8% decline so far in 2026. Surprisingly, despite its core medical focus, the company also holds 26.8% of its patents in Printed Circuits & Electronic Assemblies, a category that experienced a dramatic 400.0% surge in 2025, indicating a potential emerging focus on the underlying hardware components of its medical devices.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
56 US filings (since 2023) · 4 categories · 3 themes
Development of devices and methods for non-invasive or minimally invasive collection and analysis of physiological data, often from wearable sensors, to monitor health, activity, or specific conditions.
Systems and methods for non-invasive or minimally invasive collection and analysis of physiological data (e.g., blood pressure, electrolytes, genetic markers, B cell repertoire) to assess patient health status, screen for conditions, or aid in diagnosis.
Utilizing machine learning, particularly deep learning, to analyze medical data such as images, sensor readings, or physiological signals for disease prediction, diagnosis, or treatment assessment.
Patents
Showing 11-20 of 91